Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.9%

7 terminated/withdrawn out of 740 trials

Success Rate

96.2%

+9.7% vs industry average

Late-Stage Pipeline

9%

66 trials in Phase 3/4

Results Transparency

3%

6 of 176 completed trials have results

Key Signals

125 recruiting6 with results6 withdrawn

Enrollment Performance

Analytics

N/A
192(40.4%)
Phase 1
114(24.0%)
Phase 2
97(20.4%)
Phase 4
43(9.1%)
Phase 3
23(4.8%)
Early Phase 1
6(1.3%)
475Total
N/A(192)
Phase 1(114)
Phase 2(97)
Phase 4(43)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (740)

Showing 20 of 740 trials
NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: lead

NCT07529028Not ApplicableNot Yet Recruiting

Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy

Role: collaborator

NCT07527026Phase 2Recruiting

A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer

Role: lead

NCT07525037Not Yet Recruiting

Chinese, Overweight or Obesity, Real-World Registry Study

Role: lead

NCT07511595Not Yet Recruiting

Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients

Role: collaborator

NCT06084819Phase 2Recruiting

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Role: lead

NCT06713291Not ApplicableRecruiting

Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures

Role: lead

NCT06119256Phase 1Recruiting

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Role: lead

NCT07494981Not Yet Recruiting

Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations

Role: lead

NCT07496008Not Yet Recruiting

Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population

Role: lead

NCT06969807Phase 2Recruiting

Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease

Role: lead

NCT07489157Not ApplicableNot Yet Recruiting

Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy

Role: lead

NCT07494526Not Yet Recruiting

Chronic Kidney Disease and Metabolic Disorders in the Elderly

Role: lead

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT06316895Recruiting

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Role: lead

NCT06928376Phase 2Active Not Recruiting

A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients

Role: lead

NCT07009873Recruiting

Clinical Application of Wearable Ultrasound Sensors

Role: lead

NCT07101588Phase 4Recruiting

Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

Role: lead

NCT06340945Not ApplicableRecruiting

The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

Role: lead